Suppr超能文献

多西他赛在人细胞色素P450中的代谢:与紫杉醇及其他抗肿瘤药物的相互作用

Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.

作者信息

Royer I, Monsarrat B, Sonnier M, Wright M, Cresteil T

机构信息

Laboratoire de Pharmacologie et Toxicologie Fondamentales, UPR 8221, Toulouse, France.

出版信息

Cancer Res. 1996 Jan 1;56(1):58-65.

PMID:8548776
Abstract

The metabolism of docetaxel by human liver microsomes was investigated in vitro and compared with that of paclitaxel. A main docetaxel metabolite was generated by human liver microsomes in the presence of NADPH: retention time in high pressure liquid chromatography and its ion fragmentation in mass spectrometry were identical to those of the authentic derivative hydroxylated at the butyl group of the C13 side chain. Kinetic measurements and chemical and immunological inhibitions demonstrated that CYP3A was implicated in the hydroxylation of docetaxel: Km (2 microM) and Vm values of docetaxel for human liver microsomes were comparable to those calculated for the formation of metabolite p-hydroxy-phenyl C3' paclitaxel (M4). Docetaxel hydroxylation correlated only with the CYP3A content of microsomes and with CYP3A-dependent 6 beta-hydroxylation of testosterone and 16-hydroxylation of dehydroepiandrosterone. The formation of hydroxydocetaxel was strongly reduced by CYP3A inhibitors such as ketoconazole, midazolam, erythromycin, testosterone, orphenadrine, and troleandomycin, whereas quinidine (CYP2D6), hexobarbital, tolbutamide, and mephenytoin (CYP2C) had no or little effect. The hydroxylation of docetaxel exhibited a highly positive correlation with the formation of metabolite M4 of paclitaxel (r = 0.929, P < 0.0001, n = 12), but not with its 6-hydroxylation (r = 0.48, P > 0.15). Docetaxel abolished the hydroxylation of paclitaxel metabolite M4, but was totally inactive on its 6 alpha-hydroxylation. Conversely, paclitaxel reduced significantly the hydroxylation of docetaxel. We examined in vitro the possible interaction among docetaxel, paclitaxel, and drugs which could be associated during chemotherapy. Cisplatin, verapamil, doxorubicin, vinblastine, and vincristine at concentrations usually recommended did not markedly modify taxoid metabolism. Ranitidine and diphenylhydramine had no effect, but 100 microM cimetidine partially inhibited the formation of 6 alpha-hydroxypaclitaxel. Pretreatment of patients with barbiturates strikingly stimulated docetaxel hydroxylation, whereas no acceleration of docetaxel hydroxylation was noticed in a patient receiving steroids.

摘要

在体外研究了多西他赛在人肝微粒体中的代谢情况,并与紫杉醇的代谢进行了比较。在存在NADPH的情况下,人肝微粒体产生了一种主要的多西他赛代谢产物:其在高压液相色谱中的保留时间及其在质谱中的离子碎片与在C13侧链丁基处羟基化的真实衍生物相同。动力学测量以及化学和免疫抑制实验表明,CYP3A参与了多西他赛的羟基化反应:多西他赛在人肝微粒体中的Km(2 microM)和Vm值与计算得到的代谢产物对羟基苯基C3'紫杉醇(M4)形成时的值相当。多西他赛的羟基化仅与微粒体中的CYP3A含量以及睾酮的CYP3A依赖性6β-羟基化和脱氢表雄酮的16-羟基化相关。酮康唑、咪达唑仑、红霉素、睾酮、苯海拉明和醋竹桃霉素等CYP3A抑制剂可显著降低羟基多西他赛的形成,而奎尼丁(CYP2D6)、己巴比妥、甲苯磺丁脲和美芬妥英(CYP2C)则无作用或作用很小。多西他赛的羟基化与紫杉醇代谢产物M4的形成呈高度正相关(r = 0.929,P < 0.0001,n = 12),但与其6-羟基化无关(r = 0.48,P > 0.15)。多西他赛可消除紫杉醇代谢产物M4的羟基化,但对其6α-羟基化完全无活性。相反,紫杉醇可显著降低多西他赛的羟基化。我们在体外研究了多西他赛、紫杉醇以及化疗期间可能联合使用的药物之间的相互作用。通常推荐浓度的顺铂、维拉帕米、阿霉素、长春碱和长春新碱并未显著改变紫杉烷类药物的代谢。雷尼替丁和苯海拉明无作用,但100 microM西咪替丁可部分抑制6α-羟基紫杉醇的形成。用巴比妥类药物预处理患者可显著刺激多西他赛的羟基化,而在接受类固醇治疗的患者中未观察到多西他赛羟基化加速。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验